» Articles » PMID: 16452181

The C-myc Gene is a Direct Target of Mammalian SWI/SNF-related Complexes During Differentiation-associated Cell Cycle Arrest

Overview
Journal Cancer Res
Specialty Oncology
Date 2006 Feb 3
PMID 16452181
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

The activity of mammalian SWI/SNF-related chromatin remodeling complexes is crucial for differentiation, development, and tumor suppression. Cell cycle-regulating activities dependent on the complexes include induction of the p21(WAF1/CIP1) kinase inhibitor and repression of E2F-responsive promoters. These responses are linked through effects on pRb phosphorylation, but the direct role of the SWI/SNF-related complexes in their regulation is not fully understood. Results presented here reveal that the complexes are required for regulation of a distinct pathway of proliferation control involving repression of c-myc expression in differentiating cells. This involves direct promoter targeting of the c-myc gene by the complexes. Induction of p21(WAF1/CIP1) is specifically dependent on prior repression of c-myc, but repression of E2F-responsive genes is dissociable from the regulation of c-myc and p21(WAF1/CIP1).

Citing Articles

Untangling the Role of MYC in Sarcomas and Its Potential as a Promising Therapeutic Target.

Sias F, Zoroddu S, Migheli R, Bagella L Int J Mol Sci. 2025; 26(5).

PMID: 40076599 PMC: 11900228. DOI: 10.3390/ijms26051973.


Integrative multi-omics profiling of colorectal cancer from a Hispanic/Latino cohort of patients.

Waldrup B, Carranza F, Jin Y, Amzaleg Y, Postel M, Craig D medRxiv. 2024; .

PMID: 39606335 PMC: 11601710. DOI: 10.1101/2024.11.03.24316599.


Genetic Alterations in Invasive Breast Carcinoma with a Glycogen-Rich Clear Cell Pattern: A Case Report.

De La Sancha C, Ruiz-Cordero R, Popnikolov N Case Rep Oncol. 2024; 14(1):500-505.

PMID: 38352277 PMC: 10862076. DOI: 10.1159/000514978.


The Role of the AT-Rich Interaction Domain 1A Gene () in Human Carcinogenesis.

Li J, Lee C Genes (Basel). 2024; 15(1).

PMID: 38275587 PMC: 10815128. DOI: 10.3390/genes15010005.


GLS1 is a protective factor in patients with ovarian clear cell carcinoma and its expression does not correlate with ARID1A-mutated tumors.

Clemente V, Hoshino A, Shetty M, Nelson A, Erickson B, Baker R Cancer Res Commun. 2022; 2(8):784-794.

PMID: 36082022 PMC: 9451103. DOI: 10.1158/2767-9764.crc-22-0122.